← All companies
REVB
Revelation Biosciences, Inc.
$1.02
+0.07 +7.37%
Key statistics
from XBRL data in SEC filingsMarket cap
$3.99M
Revenue (TTM)
—
Net income (TTM)
-$9.87M
EPS (TTM)
$-1.32
P/E ratio
—
Dividend yield
—
Free cash flow
-$8.29M
Cash
$14.1M
Total assets
$15.0M
Gross margin
—
52-week range
$0.88 – $11.72
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure
Jul 13, 2026
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results
Jun 24, 2026
8-K
Other events
Jun 1, 2026
8-K
Results of operations (earnings release)
May 7, 2026
10-Q
Quarter ended 2026-03-31
May 7, 2026
8-K
Modified rights of security holders; Shareholder vote results
Mar 19, 2026
8-K
Results of operations (earnings release)
Feb 26, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Modified rights of security holders
Jan 29, 2026
8-K
Other events
Jan 22, 2026
8-K
Modified rights of security holders; Shareholder vote results; Other events
Dec 3, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Regulation FD disclosure
Oct 29, 2025
8-K
Regulation FD disclosure
Oct 15, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events
Sep 15, 2025
8-K
Other events
Sep 9, 2025
8-K
Results of operations (earnings release)
Aug 8, 2025
10-Q
Quarter ended 2025-06-30
Aug 8, 2025
8-K
Modified rights of security holders; Amended charter or bylaws; Other events
Jul 9, 2025
8-K
Shareholder vote results; Other events
Jun 25, 2025
8-K
Entered a material agreement; Modified rights of security holders; Other events
Jun 4, 2025
8-K
Director or officer change; Other events
May 28, 2025
8-K
Results of operations (earnings release)
May 8, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Other events
Mar 17, 2025
8-K
Results of operations (earnings release)
Mar 6, 2025
10-K
Fiscal year ended 2024-12-31
Mar 6, 2025
8-K
Other events
Feb 24, 2025
8-K
Other events
Feb 11, 2025
8-K
Modified rights of security holders; Amended charter or bylaws
Jan 30, 2025
8-K
Shareholder vote results; Other events
Jan 21, 2025
8-K
Delisting notice or listing-rule failure; Other events
Jan 7, 2025
8-K
Other events
Dec 12, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events
Dec 6, 2024
8-K
Results of operations (earnings release)
Nov 8, 2024
10-Q
Quarter ended 2024-09-30
Nov 8, 2024
8-K
Delisting notice or listing-rule failure
Oct 21, 2024
8-K
Other events
Sep 27, 2024
10-Q/A
Quarter ended 2024-06-30
Sep 23, 2024